Filing Details

Accession Number:
0001179110-21-000315
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-01-06 16:06:27
Reporting Period:
2021-01-04
Accepted Time:
2021-01-06 16:06:27
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1070081 Ptc Therapeutics Inc. PTCT Pharmaceutical Preparations (2834) 043416587
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1578850 Gregory Neil Almstead C/O Ptc Therapeutics, Inc.
100 Corporate Court
South Plainfield NJ 07080
Chief Technical Ops Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-01-04 7,229 $27.05 34,318 No 4 M Direct
Common Stock Disposition 2021-01-04 7,229 $60.59 27,089 No 4 S Direct
Common Stock Acquisiton 2021-01-04 32,771 $27.05 59,860 No 4 M Direct
Common Stock Disposition 2021-01-04 32,571 $60.58 27,289 No 4 S Direct
Common Stock Disposition 2021-01-04 200 $61.25 27,089 No 4 S Direct
Common Stock Acquisiton 2021-01-04 3,035 $11.23 30,124 No 4 M Direct
Common Stock Disposition 2021-01-04 2,935 $60.56 27,189 No 4 S Direct
Common Stock Disposition 2021-01-04 100 $61.36 27,089 No 4 S Direct
Common Stock Acquisiton 2021-01-04 2,188 $11.23 29,277 No 4 M Direct
Common Stock Disposition 2021-01-04 2,188 $60.54 27,089 No 4 S Direct
Common Stock Acquisiton 2021-01-04 4,188 $18.01 31,277 No 4 M Direct
Common Stock Disposition 2021-01-04 4,188 $60.59 27,089 No 4 S Direct
Common Stock Acquisiton 2021-01-04 5,715 $11.23 32,804 No 4 M Direct
Common Stock Disposition 2021-01-04 5,615 $60.56 27,189 No 4 S Direct
Common Stock Disposition 2021-01-04 100 $61.24 27,089 No 4 S Direct
Common Stock Acquisiton 2021-01-04 187 $18.01 27,276 No 4 M Direct
Common Stock Disposition 2021-01-04 187 $60.61 27,089 No 4 S Direct
Common Stock Acquisiton 2021-01-04 48,125 $18.01 75,214 No 4 M Direct
Common Stock Disposition 2021-01-04 47,936 $60.58 27,278 No 4 S Direct
Common Stock Disposition 2021-01-04 189 $61.24 27,089 No 4 S Direct
Common Stock Acquisiton 2021-01-04 600 $10.85 2,512 No 4 M Indirect By Spouse
Common Stock Disposition 2021-01-04 600 $60.65 1,912 No 4 S Indirect By Spouse
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 M Indirect By Spouse
No 4 S Indirect By Spouse
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right To Buy) Disposition 2021-01-04 7,229 $27.05 7,229 $27.05
Common Stock Stock Option (Right to Buy) Disposition 2021-01-04 32,771 $27.05 32,771 $27.05
Common Stock Stock Option (Right to Buy) Disposition 2021-01-04 3,035 $11.23 3,035 $11.23
Common Stock Stock Option (Right to Buy) Disposition 2021-01-04 2,188 $11.23 2,188 $11.23
Common Stock Stock Option (Right To Buy) Disposition 2021-01-04 4,188 $18.01 4,188 $18.01
Common Stock Stock Option (Right to Buy) Disposition 2021-01-04 5,715 $11.23 5,715 $11.23
Common Stock Stock Option (Right to Buy) Disposition 2021-01-04 187 $18.01 187 $18.01
Common Stock Stock Option (Right to Buy) Disposition 2021-01-04 48,125 $18.01 48,125 $18.01
Common Stock Stock Option (Right to Buy) Disposition 2021-01-04 600 $10.85 600 $10.85
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
32,771 2024-01-27 No 4 M Direct
0 2024-01-27 No 4 M Direct
7,903 2027-01-02 No 4 M Direct
5,715 2027-01-02 No 4 M Direct
65,812 2028-01-02 No 4 M Direct
0 2027-01-02 No 4 M Direct
65,625 2028-01-02 No 4 M Direct
17,500 2028-01-02 No 4 M Direct
0 2023-05-15 No 4 M Indirect
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Stock Option (Right To Buy) $490.80 2021-04-27 216 216 Direct
Common Stock Stock Option (Right To Buy) $218.40 2022-01-10 166 166 Direct
Common Stock Stock Option (Right To Buy) $51.00 2025-01-01 69,550 69,550 Direct
Common Stock Stock Option (Right To Buy) $30.86 2026-01-03 55,000 55,000 Direct
Common Stock Stock Option (Right To Buy) $33.02 2029-01-21 72,500 72,500 Direct
Common Stock Stock Option (Right To Buy) $33.02 2029-01-21 17,500 17,500 Direct
Common Stock Stock Option (Right To Buy) $51.16 2030-01-28 69,500 69,500 Direct
Common Stock Stock Option (Right to Buy) $490.80 2021-04-27 7 7 Indirect
Common Stock Stock Option (Right to Buy) $218.40 2022-01-10 7 7 Indirect
Common Stock Stock Option (Right to Buy) $27.05 2024-01-27 1,300 1,300 Indirect
Common Stock Stock Option (Right to Buy) $51.00 2025-01-01 2,060 2,060 Indirect
Expiration Date Amount Remaning Holdings Nature of Ownership
2021-04-27 216 216 Direct
2022-01-10 166 166 Direct
2025-01-01 69,550 69,550 Direct
2026-01-03 55,000 55,000 Direct
2029-01-21 72,500 72,500 Direct
2029-01-21 17,500 17,500 Direct
2030-01-28 69,500 69,500 Direct
2021-04-27 7 7 Indirect
2022-01-10 7 7 Indirect
2024-01-27 1,300 1,300 Indirect
2025-01-01 2,060 2,060 Indirect
Footnotes
  1. The transactions reported in this Form 4 were effected pursuant to written a Rule 10b5-1 plan adopted by the Reporting Person on November 24, 2020.
  2. This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $60.40 to $61.25 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
  3. This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $60.18 to $61.12 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
  4. This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $61.24 to $61.25 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
  5. The transactions reported in this Form 4 were effected pursuant to written a Rule 10b5-1 plan adopted by the Reporting Person on November 10, 2020.
  6. This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $60.22 to $60.95 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
  7. This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $60.42 to $60.75 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
  8. This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $60.39 to $61.24 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
  9. This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $60.20 to $61.07 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
  10. This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $60.40 to $61.24 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
  11. This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $60.18 to $61.12 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
  12. The transactions reported in this Form 4 were effected pursuant to written a Rule 10b5-1 plan adopted by the spouse of the Reporting Person on November 10, 2020.
  13. Currently exercisable.
  14. This option was granted on January 3, 2018, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2019, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2019.
  15. This option was granted on January 22, 2019 and vests over four years, with 25% of the shares underlying the option vesting on January 22, 2020, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning April 22, 2020.
  16. This option was granted on January 22, 2019 and vests over four years, with 50% of the shares underlying the option vesting on January 22, 2022, and the remaining 50% of the original number of shares underlying the option vesting on January 22, 2023.
  17. This option was granted on January 29, 2020, and vests over four years, with 25% of the shares underlying the option vesting on January 29, 2021, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 29, 2021.